Patients on MET had a 46% reduction in head/neck cancers & 55% in stomach cancers.
The evidence is convergent. Multiple independent sources reach the same conclusion, the underlying mechanism is well-characterized, and even the field's most cautious voices treat it as worth doing.
Patients on MET had a 46% reduction in head/neck cancers & 55% in stomach cancers.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
and there are hundreds of studies that show the association between metformin and less cancers and not only that less all cancer except prostate by the way prostate is hanging there maybe a little bit
The work, the studies done with metformin and showing that people who, type 2 diabetics that are taking metformin have a 62% less chance of getting pancreatic cancer.